I am a
Home I AM A Search Login

Papers of the Week

2022 Aug 19

Ecotoxicol Environ Saf


Ambient ozone, and urban PM co-exposure, aggravate allergic asthma via transient receptor potential vanilloid 1-mediated neurogenic inflammation.


Lian Z, Qi H, Liu X, Zhang Y, Xu R, Yang X, Zeng Y, Li J
Ecotoxicol Environ Saf. 2022 Aug 19; 243:114000.
PMID: 35994908.


Allergic asthma is the most common pulmonary inflammatory disease, and epidemiological studies have revealed that PM or ambient ozone (O) exposure contribute to the higher prevalence of allergic asthma. Current experimental evidence focus principally on the pathogenic effect of exposure to a single air pollutant, ignoring the possible synergistic effect of combined exposure to a mix of these pollutants, which is a more realistic scenario. In this study, allergic mice and a nociceptor antagonist were used to explore the mechanisms of co-exposure to these two important air pollutants. Compared with exposure to either PM or O, combined exposure to both greatly aggravated allergic asthma in a dose dependent manner, including increased airway hyperresponsiveness, goblet cell metaplasia, more severe airway inflammation and higher oxidative stress levels. In addition, co-exposure in the allergic mice resulted in elevation of the expression of transient receptor potential vanilloid 1 (TRPV1), and of the production of substance P (SP), which exacerbated lung inflammation by neurogenic inflammation. TRPV1 antagonist (capsazepine, CPZ) treatment for the co-exposed allergic mice, markedly attenuated TRPV1 expression and SP release, and reduced airway inflammation and oxidative damage, further alleviating airway hyperresponsiveness. We conclude that neuro-immune interactions might be involved in PM and O co-exposure aggravated allergic asthma.